EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future

Dalgisio Lecis, Gianluca Massaro iD, Daniela Benedetto, Marco Di Luozzo, Giulio Russo, Alessandro Mauriello iD, Massimo Federici, Giuseppe Massimo Sangiorgi iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241310979 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Dalgisio Lecis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, "Tor Vergata" University Hospital, Viale Oxford 81, 00133 Rome, Italy. Hauptthemen laut MEDLINE: Atherosclerosis, Immunomodulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerotic cardiovascular disease is the most common cause of morbidity and death worldwide. Recent studies have demonstrated that this chronic inflammatory disease of the arterial wall can be controlled through the modulation of immune system activity. Many patients with cardiovascular disease remain at elevated risk of recurrent events despite receiving current, state-of-the-art preventive medical treatment. Much of this residual risk is attributed to inflammation. Therefore, finding new treatment strategies for this category of patients became of common interest. This review will discuss the experimental and clinical data supporting the possibility of developing immune-based therapies for lowering cardiovascular risk, explicitly focusing on vaccination strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisImmunomodulationHumansHeart Disease Risk FactorsInflammationVaccinationImmunity, InnateAdaptive ImmunityImmunity, HumoralAutoantigensClinical Trials as TopicVaccines

Stichwörter der Autor:innen

atherosclerosiscardiovascular diseaseimmune-modulation therapiesinflammationvaccine

Substanzen

AutoantigensVaccines

Autor:innen und Institutionen

  • Division of Cardiology, "Tor Vergata" University Hospital, Viale Oxford 81, 00133 Rome, Italy.
  • Department of Experimental Medicine, University "Tor Vergata", 00133 Rome, Italy.
  • Department of Systemic Medicine, University "Tor Vergata", 00133 Rome, Italy.
  • Department of Biomedicine and Prevention, "Tor Vergata" University of Rome, 00133 Rome, Italy.

ORCID-Profile: Gianluca Massaro, Alessandro Mauriello, Giuseppe Massimo Sangiorgi

Zitieren

APA

Lecis, D., Massaro, G., Benedetto, D., Di Luozzo, M., Russo, G., Mauriello, A., Federici, M., & Sangiorgi, G. M. (2023). Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241310979

Vancouver

Lecis D, Massaro G, Benedetto D, Di Luozzo M, Russo G, Mauriello A, et al. Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241310979

BibTeX
@article{Lecis2023,
  author = {Lecis, Dalgisio and Massaro, Gianluca and Benedetto, Daniela and Di Luozzo, Marco and Russo, Giulio and Mauriello, Alessandro and Federici, Massimo and Sangiorgi, Giuseppe Massimo},
  title = {Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241310979}
}
Kostenlos starten →